Across TCGA pan-cancer cohorts, DDX58 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated DDX58 data layer compared with 24 for mass-spec protein and 4 for mutation status.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher DDX58 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated DDX58 expression acts as an unfavorable survival marker, although some lineages such as HNSC and LUAD show a favorable association.
COAD, HNSC, and LUAD are the cancer types where DDX58 mass-spec protein most reproducibly stratifies survival.